Human RFT1 Deficiency Leads to a Disorder of N-Linked Glycosylation

Institute of Physiology and Zürich Center for Integrative Human Physiology, University of Zürich, Winterthurerstrasse 190, CH-8057 Zürich, Switzerland.
The American Journal of Human Genetics (Impact Factor: 10.99). 03/2008; 82(3):600-6. DOI: 10.1016/j.ajhg.2007.12.021
Source: PubMed

ABSTRACT N-linked glycosylation is an essential posttranslational modification of proteins in eukaryotes. The substrate of N-linked glycosylation, dolichol pyrophosphate (DolPP)-GlcNAc(2)Man(9)Glc(3), is assembled through a complex series of ordered reactions requiring the translocation of the intermediate DolPP-GlcNAc(2)Man(5) structure across the endoplasmic-reticulum membrane. A young patient diagnosed with a congenital disorder of glycosylation characterized by an intracellular accumulation of DolPP-GlcNAc(2)Man(5) was found to carry a homozygous point mutation in the RFT1 gene. The c.199C-->T mutation introduced the amino acid substitution p.R67C. The human RFT1 protein shares 22% identity with its yeast ortholog, which is involved in the translocation of DolPP-GlcNAc(2)Man(5) from the cytosolic into the lumenal side of the endoplasmic reticulum. Despite the low sequence similarity between the yeast and the human RFT1 proteins, we demonstrated both their functional orthology and the pathologic effect of the human p.R67C mutation by complementation assay in Deltarft1 yeast cells. The causality of the RFT1 p.R67C mutation was further established by restoration of normal glycosylation profiles in patient-derived fibroblasts after lentiviral expression of a normal RFT1 cDNA. The definition of the RFT1 defect establishes the functional conservation of the DolPP-GlcNAc(2)Man(5) translocation process in eukaryotes. RFT1 deficiency in both yeast and human cells leads to the accumulation of incomplete DolPP-GlcNAc(2)Man(5) and to a profound glycosylation disorder in humans.

Download full-text


Available from: Bryan Winchester, Aug 30, 2015
  • Source
    • "Human TMEM27 cDNA sequence was subcloned as a PCR fragment flanked by SmaI and XhoI restriction sites into the Eco47III and XhoI sites of pLenti6-EGFP (Life Technologies), thus yielding to pLenti6-TMEM27 vector. Lentiviral production was performed according to the protocol described elsewhere [29]. Infected MDCK cells were selected with 6 µg/mL blasticidin S (Life Technologies). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Gene expression and cell growth rely on the intracellular concentration of amino acids, which in metazoans depends on extracellular amino acid availability and transmembrane transport. To investigate the impact of extracellular amino acid concentrations on the expression of a concentrative amino acid transporter, we overexpressed the main kidney proximal tubule luminal neutral amino acid transporter B0AT1-collectrin (SLC6A19-TMEM27) in MDCK cell epithelia. Exogenously expressed proteins co-localized at the luminal membrane and mediated neutral amino acid uptake. However, the transgenes were lost over few cell culture passages. In contrast, the expression of a control transgene remained stable. To test whether this loss was due to inappropriately high amino acid uptake, freshly transduced MDCK cell lines were cultivated either with physiological amounts of amino acids or with the high concentration found in standard cell culture media. Expression of exogenous transporters was unaffected by physiological amino acid concentration in the media. Interestingly, mycoplasma infection resulted in a significant increase in transgene expression and correlated with the rapid metabolism of L-arginine. However, L-arginine metabolites were shown to play no role in transgene expression. In contrast, activation of the GCN2 pathway revealed by an increase in eIF2α phosphorylation may trigger transgene derepression. Taken together, high extracellular amino acid concentration provided by cell culture media appears to inhibit the constitutive expression of concentrative amino acid transporters whereas L-arginine depletion by mycoplasma induces the expression of transgenes possibly via stimulation of the GCN2 pathway.
    PLoS ONE 05/2014; 9(5):e96823. DOI:10.1371/journal.pone.0096823 · 3.23 Impact Factor
  • Source
    • "The human RFT1 protein with its 541 amino acids spans the ER membrane 11 times according to prediction algorithms ( Fig . 15 ) . The asparagine at position p . N227 might be N - glycosylated . All five identified point mutations convert strongly conserved amino acids ( Supp . Table S15 ) [ Haeuptle et al . , 2008 ; Vleugels et al . , in press ] ."
    [Show abstract] [Hide abstract]
    ABSTRACT: Defects in the biosynthesis of the oligosaccharide precursor for N-glycosylation lead to decreased occupancy of glycosylation sites and thereby to diseases known as congenital disorders of glycosylation (CDG). In the last 20 years, approximately 1,000 CDG patients have been identified presenting with multiple organ dysfunctions. This review sets the state of the art by listing all mutations identified in the 15 genes (PMM2, MPI, DPAGT1, ALG1, ALG2, ALG3, ALG9, ALG12, ALG6, ALG8, DOLK, DPM1, DPM3, MPDU1, and RFT1) that yield a deficiency of dolichol-linked oligosaccharide biosynthesis. The present analysis shows that most mutations lead to substitutions of strongly conserved amino acid residues across eukaryotes. Furthermore, the comparison between the different forms of CDG affecting dolichol-linked oligosaccharide biosynthesis shows that the severity of the disease does not relate to the position of the mutated gene along this biosynthetic pathway.
    Human Mutation 12/2009; 30(12):1628-41. DOI:10.1002/humu.21126 · 5.05 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Glycoprotein synthesis is one of the major duties of the liver. During the last decade a large number of inherited disorders in protein glycosylation have been identified that alter the architecture and function of the liver. Many congenital disorders of glycosylation (CDG) compromise the synthesis of a host of membrane and secreted glycoproteins often leading to steatosis, hepatic fibrosis, and abnormal bile duct architecture. Misfolded glycoproteins accumulate in the endoplasmic reticulum (ER) and improperly glycosylated plasma proteins are frequently unstable, leading to pro- or anti-coagulant status. CDG patients with liver pathology often present with a host of abnormalities in other systems, including the gastrointestinal tract causing protein-losing enteropathy, hypotonia, hypoglycemia, developmental delay, and seizures. In some cases, pathology is primarily confined to the liver. Effective therapy is available for only one of the more than 20 types of CDG. A simple and inexpensive serum transferrin glycosylation test can suggest a glycosylation disorder and should be used early on in a diagnostic workup of any patients with unknown liver-related pathology, especially if it occurs in combination with abnormalities in other organ systems. Many CDG patients probably remain undiagnosed.
Show more